Io

AstraZeneca’s Imfinzi (durvalumab) approved in the US for new four-week 1,500mg fixed-dosing option

(PRESS RELEASE) CAMBRIDGE, 20-Nov-2020 — /EuropaWire/ — AstraZeneca (LON: AZN), a global, science-led biopharmaceutical company, has announced the US Food…

3 years ago

SGS brings its Internet of Things (IoT) expertise to the ITS-NY exhibition

GENEVA, 16-Jun-2017 — /EuropaWire/ — SGS will be at the ITS-NY exhibition on June 15 and 16, 2017. Data analytics solutions…

7 years ago